Reuters logo
BRIEF-Abbott Q1 adjusted earnings per share $0.48 from continuing operations
April 19, 2017 / 11:51 AM / 7 months ago

BRIEF-Abbott Q1 adjusted earnings per share $0.48 from continuing operations

April 19 (Reuters) - Abbott Laboratories:

* Abbott reports first-quarter 2017 results

* Q1 adjusted earnings per share $0.48 from continuing operations

* Q1 GAAP earnings per share $0.22 from continuing operations

* Q1 earnings per share view $0.43 -- Thomson Reuters I/B/E/S

* Sees FY 2017 adjusted earnings per share $2.40 to $2.50 from continuing operations

* Q1 sales $6.3 billion versus I/B/E/S view $6.16 billion

* Abbott Laboratories - Q1 worldwide sales of $6.3 billion increased 29.7 percent on a reported basis and 3.2 percent on a comparable operational basis

* Q1 total nutrition sales $1,642 million, down 1.7 percent on reported basis

* Abbott’s full-year earnings-per-share guidance remains unchanged

* Abbott Laboratories says q1 total pediatric sales $927 million, down 4.1 percent on a reported basis

* Abbott Laboratories - Q1 total diagnostics sales $1,158 million, up 3.6 percent on a reported basis

* Abbott Laboratories - Q1 total vascular sales $703 million, up 16.9 percent on a reported basis

* Abbott-Integration of St. Jude going well, recently launched products contributing to double-digit sales growth across several areas of medical devices unit Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below